Literature DB >> 9841974

Cationic liposome-mediated gene transfer during acute pancreatitis: tissue specificity, duration, and effects of acute inflammation.

W Denham1, J Yang, S MacKay, C Tannahill, G Carter, A Abouhamze, L L Moldawer, J Norman.   

Abstract

Production of inflammatory cytokines in the pancreas, lung, and liver is believed to play a major role in the development of severe pancreatitis. This tissue-specific production could lend itself to directed anti-cytokine gene therapy if an appropriate delivery system could be developed. This study was undertaken to examine a novel approach for the delivery of protein-based therapies to the tissues involved during acute pancreatitis. Healthy mice received an intraperitoneal injection of cationic liposomes and a DNA plasmid containing the chloramphenicol acetyltransferase (CAT) reporter gene. Animals were killed at 12 hours and 1, 2, 3, 7, and 14 days with serum, pancreas, lung, and liver harvested. Acute pancreatitis was induced (cerulein, 50 micrograms/kg/hr intraperitoneally x4) in additional mice before or after CAT transfection. The presence of pancreatitis was established in all animals by histologic scoring of pancreata and by serum amylase and lipase levels. CAT transfection efficiency was determined by quantitative CAT enzyme activity within tissue homogenates. Animals that received the liposome were successfully transfected with the CAT gene into the pancreas, lungs, and liver. Maximal transfection in each tissue occurred at 12 hours with decreasing CAT activity over the ensuing 14 days. No healthy animals receiving the CAT gene developed elevations in amylase, lipase, or any histologic parameter of pancreatitis. Transfection efficiency in the pancreas was markedly increased by preexisting or delayed induction of pancreatitis, whereas transfection of the lung and liver was increased to a lesser extent. Gene transfection into the pancreas, liver, and lungs is possible using a cationic liposome delivery system that does not induce pancreatitis or pancreatic inflammation. Pancreatic expression of the gene product is equal to or greater than that of the organs of the reticuloendothelial system and continues at very high efficiency rates during acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9841974     DOI: 10.1016/s1091-255x(98)80109-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  20 in total

1.  The cytomegalovirus enhancer: a pan-active control element in transgenic mice.

Authors:  E V Schmidt; G Christoph; R Zeller; P Leder
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

2.  In vivo gene delivery. Efficient transfection of T lymphocytes in adult mice.

Authors:  R Philip; D Liggitt; M Philip; P Dazin; R Debs
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

3.  No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes.

Authors:  A E Canonico; J D Plitman; J T Conary; B O Meyrick; K L Brigham
Journal:  J Appl Physiol (1985)       Date:  1994-07

4.  Adenovirus-mediated in vivo gene transfer and expression in normal rat pancreas.

Authors:  S E Raper; R P DeMatteo
Journal:  Pancreas       Date:  1996-05       Impact factor: 3.327

5.  Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction.

Authors:  J G Norman; G W Fink; W Denham; J Yang; G Carter; C Sexton; J Falkner; W R Gower; M G Franz
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

6.  Cationic liposome-mediated intravenous gene delivery.

Authors:  Y Liu; D Liggitt; W Zhong; G Tu; K Gaensler; R Debs
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

7.  Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression.

Authors:  J G Norman; G W Fink; M G Franz
Journal:  Arch Surg       Date:  1995-09

8.  Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis.

Authors:  J Norman; M Franz; J Messina; A Riker; P J Fabri; A S Rosemurgy; W R Gower
Journal:  Surgery       Date:  1995-06       Impact factor: 3.982

9.  Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes.

Authors:  R Philip; E Brunette; L Kilinski; D Murugesh; M A McNally; K Ucar; J Rosenblatt; T B Okarma; J S Lebkowski
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

10.  Systemic gene therapy: biodistribution and long-term expression of a transgene in mice.

Authors:  A R Thierry; Y Lunardi-Iskandar; J L Bryant; P Rabinovich; R C Gallo; L C Mahan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

View more
  2 in total

1.  Adenoviral gene delivery to primary human cutaneous cells and burn wounds.

Authors:  Tobias Hirsch; Sebastian von Peter; Grzegorz Dubin; Dominik Mittler; Frank Jacobsen; Markus Lehnhardt; Elof Eriksson; Hans-Ulrich Steinau; Lars Steinstraesser
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

2.  Transient human gene therapy: a novel cytokine regulatory strategy for experimental pancreatitis.

Authors:  W Denham; D Denham; J Yang; G Carter; S MacKay; L L Moldawer; L C Carey; J Norman
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.